Company Financials
Neurones Financials
Euro
business
Neurones Company Profile
Main Stock Listing
Euronext: NRO
Market Capitalization €1.09 Billion as of July 1, 2025
Market Cap History
Valuations Metrics as of Jul. 5, 2025
| Trailing PE | 20.67 |
| Forward PE | 20.30 |
| Price to Sales TTM | €1.34 |
| Price to Book MRQ | €2.87 |
| Enterprise to Revenue | 1.07 |
| Enterprise to EBITDA | 9.95 |
Financial Reports as of Dec. 31, 2024
Financials
| Fiscal Year Ends | 2024-12-31 |
| Most Recent Quarter | 2024-12-31 |
| Profit Margin | 6.49% |
| Operating Margin | 10.01% |
| Return on Assets TTM | 6.94% |
| Return on Equity TTM | 14.95% |
Income Statement
| Revenue TTM | €810,353,024 |
| Revenue per Share TTM | €33.39 |
| Quarterly Revenue Growth | 9.50% |
| Gross Profit TTM | €388,760,000 |
| EBITDA | €107,330,000 |
| Net Income to Common TTM | €52,556,000 |
| Diluted EPS TTM | €2.16 |
| Quarterly Earnings Growth YoY | 17.00% |
Balance Sheet
| Total Cash MRQ | €326,491,008 |
| Total Cash per Share MRQ | €13.45 |
| Total Debt MRQ | € |
| Total Debt to Equity MRQ | 9.63 |
| Current Ratio MRQ | 2.33 |
| Book Value per Share MRQ | €15.58 |
Cash Flow
| Operating Cash Flow TTM | €84,382,000 |
| Levered Free Cash Flow TTM | €69,540,248 |
NRO Stock Info as of Jul. 5, 2025
Stock Statistics
| Shares Outstanding | 24,273,712 |
| Float Shares | 23,202,756 |
| Avg 10 Volume | 6,520 |
| Avg 30 Volume | None |
| Shares Short | None |
| Short Ratio | |
| Short % of Shares | % |
| % Held by Insiders | 69.64% |
| % Held by Institutions | 13.25% |
Stock Price Summary
| Beta | 0.58 |
| Fifty Two Week Low | €39.45 |
| Fifty Two Week High | €52.00 |
| Fifty Two Week Change | 0.67% |
| Day 50 MA | €46.57 |
| Day 200 MA | €45.99 |
Dividends and Splits
| Forward Annual Dividend Rate | €5.20 |
| Forward Annual Dividend Yield | 11.54% |
| Trailing Annual Dividend Rate | €1.30 |
| Trailing Annual Dividend Yield | 2.89% |
| Payout Ratio | 55.56% |
| Dividend Date | |
| Ex Dividend Date | 2025-06-11 |
| Last Split Factor | |
| Last Split Date |